You are rewriting rough single-molecule analysis notes from Explainable Boosting Machine (EBM) into high-quality reasoning SFT data for task AMES where option (A) means is not mutagenic and option (B) means is mutagenic.

Input 1. Task playbook
# AMES mutagenicity molecular-property playbook

## neutral fraction: estimated fraction of the molecule that is neutral at the configured pH
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—lower neutral fraction (more ionized) can reduce passive membrane permeation and may contribute to “A” outcomes via lower bacterial bioavailability/exposure rather than true absence of DNA reactivity
- Brief note: For bacterial assays, limitations can arise from “differences in bioavailability,” so ionization-dependent exposure effects are plausible but not governed by a standard cutoff for neutral fraction citeturn44view0.
- Source: citeturn44view0turn39view0turn41view0

## estimated logD: estimated logD at the configured pH
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—extreme lipophilicity can impair effective exposure (e.g., precipitation/low soluble dose), potentially biasing toward “A” in Ames readouts
- Brief note: In OECD TG 471, dose selection is constrained by cytotoxicity and solubility; the recommended maximum test concentration for **soluble, non-cytotoxic** substances is 5 mg/plate or 5 μL/plate, making solubility/exposure a practical limiter for very hydrophobic substances citeturn9view0.
- Source: citeturn9view0turn44view0

## strongest acidic pKa: pKa of the strongest acidic site
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—very low (strong) acids increase anionic fraction at neutral pH, often reducing passive permeation, which can reduce effective bacterial exposure
- Brief note: The Ames test can miss some mutagens due to “differences in bioavailability,” but no standardized pKa cutoff is used to interpret mutagenicity risk in OECD TG 471 (the endpoint is driven by DNA-reactive chemistry and metabolism) citeturn44view0.
- Source: citeturn44view0turn39view0

## strongest basic pKa: pKa of the strongest basic site
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—presence of an ionizable nitrogen (often a primary amine; typically protonated near physiological pH) is associated with improved Gram-negative accumulation, which could increase effective exposure and thus reveal “B” outcomes if a DNA-reactive motif is present
- Brief note: Gram-negative accumulation guidelines (“eNTRy rules”) emphasize a **non-sterically encumbered ionizable nitrogen (particularly a primary amine)** plus rigidity/low 3D character; these are permeability/accumulation heuristics rather than mutagenicity mechanisms citeturn39view0turn21view0.
- Source: citeturn39view0turn21view0

## number of acidic sites: number of acidic ionizable sites in the molecule
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—more acidic sites often increase polarity/ionization and can reduce passive diffusion, potentially biasing toward “A” from lower exposure
- Brief note: OECD TG 471 explicitly notes that the test can miss mutagens for reasons including “differences in bioavailability,” but does not provide numeric rules mapping ionizable-site counts to outcomes citeturn44view0.
- Source: citeturn44view0turn9view0

## number of basic sites: number of basic ionizable sites in the molecule
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—having at least one non-sterically encumbered ionizable nitrogen (esp. primary amine) is associated with improved Gram-negative accumulation (can increase effective exposure)
- Brief note: eNTRy-style guidance is framed around **presence/absence** of an ionizable nitrogen rather than a “number of basic sites” cutoff; it is meant for Gram-negative accumulation, not direct DNA reactivity citeturn39view0turn21view0.
- Source: citeturn39view0turn21view0

## number of ionizable sites: total number of acidic and basic ionizable sites
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—more ionizable sites tends to increase polarity/charge states across pH, which can reduce passive permeability and effective exposure
- Brief note: Because some Ames false negatives/shortcomings are attributable to bioavailability differences, permeability-linked descriptors can matter operationally, but no stable “ionizable sites” cutoff is used for Ames interpretation citeturn44view0turn41view0.
- Source: citeturn44view0turn44view0turn41view0

## exact molecular weight: exact isotopic molecular weight
- Common threshold(s) or range(s): **Rule-of-Five** flags impaired absorption/permeation when MW > 500 (*proxy*); **Ghose** “drug-like” MW range 160–480 (*proxy*) citeturn56view0turn16view0
- Usually associated with: no consistent direction for Ames mechanistically; *proxy*—very high MW can reduce bacterial uptake/solubility and bias toward “A” outcomes via reduced exposure
- Brief note: Tester strains are engineered to improve sensitivity (including enhanced uptake for larger/hydrophobic molecules via strain features such as rfa “deep rough” mutations), so MW effects are not reliably monotonic in Ames outcomes citeturn41view0.
- Source: citeturn56view0turn16view0turn41view0turn44view0

## fraction of sp3 carbons: fraction of carbon atoms that are sp3 hybridized
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: weak *proxy* tendencies only—lower fraction sp3 (more “flat,” aromatic) can co-occur with known Ames toxicophores (e.g., polycyclic aromatic systems), which are associated with “B”
- Brief note: A concrete mutagenicity-linked anchor exists for **polycyclic aromatic systems** (see aromatic ring notes), but fraction sp3 itself is not used with a standard mutagenicity cutoff citeturn32view0turn33view2.
- Source: citeturn32view0turn33view2turn31view0

## heavy-atom count: number of non-hydrogen atoms
- Common threshold(s) or range(s): no stable Ames-specific threshold found; *proxy* “lead-like” definitions in medicinal chemistry/virtual screening commonly constrain heavy atom count to roughly the **~20–25** range (context: lead-like space, not mutagenicity) citeturn57search8turn57search12
- Usually associated with: no consistent direction for mutagenicity; *proxy*—very high heavy-atom count (large molecules) can reduce diffusion/uptake and bias toward “A” via exposure limits
- Brief note: OECD TG 471 notes bioavailability differences as a reason some mutagens are not detected; size descriptors may therefore have operational relevance without being causal for DNA reactivity citeturn44view0.
- Source: citeturn57search8turn57search12turn44view0turn41view0

## heavy-atom molecular weight: molecular weight contributed by heavy atoms
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—tracks size similarly to molecular weight / heavy-atom count (may affect exposure)
- Brief note: Practical exposure limitations in Ames (solubility/cytotoxicity; limit concentrations) are documented, but “heavy-atom molecular weight” is not a standard interpretive axis in mutagenicity practice citeturn9view0turn44view0.
- Source: citeturn9view0turn44view0turn41view0

## Labute surface area: Labute approximate surface area
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; mostly a size/shape correlate
- Brief note: Permeability/accumulation studies in Gram-negatives discuss shape/size constraints (e.g., porin passage, efflux) but do not establish a standard Labute surface area cutoff for bacterial mutagenicity prediction citeturn39view0turn46view0.
- Source: citeturn39view0turn46view0

## maximum absolute partial charge: largest absolute atomic partial charge
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—more extreme partial charges can correlate with strong electrostatics/polarity, affecting uptake/efflux rather than intrinsic DNA reactivity
- Brief note: In Gram-negative accumulation/efflux work, electrostatics and **partial positive charges** have been identified as useful parameters for assessing efflux efficiency (species/context dependent), but without a universal numeric cutoff citeturn46view0.
- Source: citeturn46view0turn39view0

## maximum partial charge: most positive atomic partial charge
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—higher positive charge character may influence porin interactions and/or efflux
- Brief note: For E. coli, “partial positive charges” are discussed as useful parameters for assessing efflux efficiency, but the literature does not standardize a threshold on an RDKit-style max-partial-charge feature citeturn46view0.
- Source: citeturn46view0turn39view0

## minimum absolute partial charge: smallest absolute atomic partial charge
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; interpret as a model feature without a standard experimental cutoff
- Brief note: Charge distributions can matter for permeability/efflux, but there is no common mutagenicity rule anchored on “minimum absolute partial charge” citeturn46view0turn44view0.
- Source: citeturn46view0turn44view0

## minimum partial charge: most negative atomic partial charge
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; *proxy*—more negative charge character can reduce passive diffusion (anion-rich molecules), affecting exposure rather than DNA reactivity
- Brief note: OECD TG 471 notes that bioavailability differences can explain some shortcomings; electrostatics-related descriptors may influence exposure, but no numeric cutoff is standardized citeturn44view0.
- Source: citeturn44view0turn46view0

## estimated logP: RDKit-estimated octanol/water partition coefficient (logP)
- Common threshold(s) or range(s): **Rule-of-Five** flags impaired absorption/permeation when logP > 5 (*proxy*); **Ghose** range −0.4 to 5.6 (*proxy*) citeturn56view0turn16view0
- Usually associated with: no consistent direction for intrinsic mutagenicity; *proxy*—very high logP can reduce usable soluble dose / increase precipitation risk, potentially biasing toward “A” via exposure limitations
- Brief note: In OECD TG 471, solubility and cytotoxicity constrain the highest test concentration (5 mg/plate or 5 μL/plate for soluble non-cytotoxic substances), so extreme hydrophobicity can matter operationally citeturn9view0.
- Source: citeturn56view0turn16view0turn9view0turn44view0

## molecular weight: molecular weight
- Common threshold(s) or range(s): **Rule-of-Five**: MW > 500 suggests impaired absorption/permeation (*proxy*); **Ghose**: 160–480 (*proxy*) citeturn56view0turn16view0
- Usually associated with: no consistent direction; *proxy*—very large MW may reduce uptake/solubility and bias toward “A” outcomes through lower exposure
- Brief note: Ames tester strains can include features that enhance uptake of large/hydrophobic molecules (e.g., rfa mutations), which weakens any simple MW→outcome rule citeturn41view0.
- Source: citeturn56view0turn16view0turn41view0turn44view0

## NH/OH group count: number of NH or OH groups
- Common threshold(s) or range(s): no stable threshold directly on “NH/OH count”; *proxy*—Rule-of-Five flags poor absorption/permeation when **H-bond donor groups > 5** citeturn56view0
- Usually associated with: no consistent direction; *proxy*—higher HBD capacity can reduce passive permeability and bias toward “A” via lower exposure
- Brief note: NH/OH count is an imperfect stand-in for H-bond donors (not every NH is a donor, e.g., amides), so interpret cautiously and prefer explicit HBD count when available citeturn56view0.
- Source: citeturn56view0turn44view0

## nitrogen/oxygen atom count: number of nitrogen and oxygen atoms
- Common threshold(s) or range(s): no stable threshold on “N/O atom count”; *proxy*—Rule-of-Five uses **H-bond acceptors > 10** (acceptors often—but not always—N/O atoms) citeturn56view0
- Usually associated with: no consistent direction; *proxy*—higher heteroatom burden often increases polarity/ionization, potentially reducing permeability and biasing toward “A” via lower exposure
- Brief note: N/O atom count overestimates acceptor capacity when atoms are protonated/amide-like; treat as a coarse polarity proxy, not a mutagenicity rule citeturn56view0.
- Source: citeturn56view0turn44view0

## aliphatic carbocycle count: number of aliphatic carbocyclic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction (by itself)
- Brief note: Ring-type counts are occasionally used in *drug-likeness* filters and permeability discussions, but Ames mutagenicity is dominated by reactive/toxicophoric substructures rather than “aliphatic carbocycles” per se citeturn44view0turn32view0.
- Source: citeturn44view0turn32view0

## aliphatic heterocycle count: number of aliphatic heterocyclic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; depends on embedded reactive motifs (e.g., strained heterocycles are different—see functional group notes)
- Brief note: Strained three-member heterocycles (e.g., epoxides/aziridines) are clear mutagenicity toxicophores, but “aliphatic heterocycle count” broadly is not used with a cutoff citeturn32view0turn33view1.
- Source: citeturn32view0turn33view1

## aliphatic ring count: number of aliphatic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction
- Brief note: Global ring counts appear in some drug-likeness heuristics, but Ames-specific interpretive rules are structural-alert driven rather than ring-count driven citeturn44view0turn32view0.
- Source: citeturn44view0turn32view0

## aromatic carbocycle count: number of aromatic carbocyclic rings
- Common threshold(s) or range(s): no stable threshold on this count alone; one task-relevant anchor is **polycyclic aromatic systems of ≥3 fused aromatic rings** (*toxicophore*) citeturn33view2
- Usually associated with: higher fused aromaticity is associated with “B” (mutagenic), particularly via DNA intercalation and/or metabolic activation (e.g., PAH diol-epoxides)
- Brief note: The ≥3 fused-ring anchor refers to *fused* polycyclic aromatic systems (not simply 3 separate phenyls) citeturn32view0turn33view2.
- Source: citeturn32view0turn33view2

## aromatic heterocycle count: number of aromatic heterocyclic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; depends on attached/embedded toxicophores (e.g., aromatic nitro/amine on heteroaromatics)
- Brief note: Aromatic nitro and aromatic amine toxicophores are well-recognized for Ames mutagenicity and can occur on heteroaromatic rings; ring-type count alone is not a sufficient rule citeturn32view0turn33view0.
- Source: citeturn32view0turn33view0turn44view0

## aromatic ring count: number of aromatic rings
- Common threshold(s) or range(s): no stable cutoff on “aromatic ring count” in general; however, **polycyclic aromatic systems (≥3 fused aromatic rings)** are a documented mutagenicity toxicophore citeturn33view2
- Usually associated with: “B” more likely when high aromaticity reflects polycyclic planar systems (intercalation) and/or aromatic bioactivation motifs
- Brief note: This is a *structural-alert* anchor (fused rings & planarity) rather than a universal numeric threshold on aromatic rings citeturn33view2turn32view0.
- Source: citeturn33view2turn32view0turn44view0

## hydrogen-bond acceptor count: number of hydrogen-bond acceptors
- Common threshold(s) or range(s): **Rule-of-Five** flags impaired absorption/permeation when H-bond acceptors > 10 (*proxy*) citeturn56view0
- Usually associated with: no consistent direction for intrinsic mutagenicity; *proxy*—very high HBA can reduce passive permeability and bias toward “A” via exposure limits
- Brief note: HBA is part of permeability-oriented heuristics (drug-likeness/absorption), while Ames outcomes are primarily governed by reactive chemistry plus metabolic activation/bioavailability citeturn56view0turn44view0.
- Source: citeturn56view0turn44view0

## hydrogen-bond donor count: number of hydrogen-bond donors
- Common threshold(s) or range(s): **Rule-of-Five** flags impaired absorption/permeation when H-bond donors > 5 (*proxy*) citeturn56view0
- Usually associated with: no consistent direction; *proxy*—many donors increase polarity and can reduce passive diffusion, potentially biasing toward “A” via reduced exposure
- Brief note: HBD is an exposure/permeability feature rather than a chemical-reactivity feature; interpret as a confounder/modifier (exposure) rather than a mechanistic mutagenicity driver citeturn44view0.
- Source: citeturn56view0turn44view0

## heteroatom count: number of heteroatoms, such as N, O, or S
- Common threshold(s) or range(s): no stable threshold found
- Usually associated with: no consistent direction; higher heteroatom count often increases polarity/ionization (*proxy* exposure modifier)
- Brief note: While heteroatom count is widely used in descriptors, mutagenicity prediction practice emphasizes structural alerts/toxicophores (e.g., nitro, aziridine, epoxide) rather than heteroatom count alone citeturn32view0.
- Source: citeturn32view0turn44view0

## rotatable-bond count: number of rotatable bonds
- Common threshold(s) or range(s): **Veber**: ≤10 rotatable bonds (*proxy for oral bioavailability/permeability*) citeturn12view0; **eNTRy (Gram-negative accumulation)**: ≤5 rotatable bonds (*proxy for bacterial accumulation*) citeturn39view0turn21view0
- Usually associated with: no consistent direction for intrinsic mutagenicity; *proxy*—lower RB (more rigid) can increase Gram-negative accumulation and may increase effective exposure, helping reveal “B” if DNA-reactive motifs exist
- Brief note: The eNTRy rule is explicitly about Gram-negative accumulation (uptake/efflux balance), not about genotoxic mechanism citeturn39view0.
- Source: citeturn12view0turn39view0turn21view0turn44view0

## saturated carbocycle count: number of saturated carbocyclic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; may inversely correlate with aromaticity (and thus with aromatic toxicophores) in some datasets
- Brief note: Saturated rings can increase 3D character, but Ames mutagenicity remains dominated by specific toxicophores rather than saturation counts citeturn32view0turn33view2.
- Source: citeturn32view0turn33view2

## saturated heterocycle count: number of saturated heterocyclic rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction; depends on whether strained electrophilic heterocycles exist (see functional group notes)
- Brief note: “Three-membered heterocycles” (e.g., epoxides/aziridines) are mutagenicity toxicophores, but saturated heterocycles overall do not have a standalone cutoff citeturn33view0turn33view1.
- Source: citeturn33view0turn33view1

## saturated ring count: number of saturated rings
- Common threshold(s) or range(s): no stable literature threshold found
- Usually associated with: no consistent direction
- Brief note: Saturation can modulate solubility/permeability and “flatness,” but no stable Ames-specific ring-saturation cutoff exists citeturn44view0turn31view0.
- Source: citeturn44view0turn31view0

## ring count: total number of rings
- Common threshold(s) or range(s): no stable Ames-specific threshold found; a commonly cited *drug-like* heuristic reports many drug-like molecules obey **1 ≤ number of rings ≤ 4** (*proxy*) citeturn16view0
- Usually associated with: no consistent direction; *proxy*—very high ring counts may reduce solubility/raise planarity, and mutagenicity risk is driven by specific toxicophores (polycyclic fused aromatics are a notable “B” anchor)
- Brief note: Distinguish “many rings” from the specific high-risk pattern **≥3 fused aromatic rings** (polycyclic planar systems) citeturn33view2.
- Source: citeturn16view0turn33view2turn44view0

## topological polar surface area: topological polar surface area of the molecule
- Common threshold(s) or range(s): **Veber**: PSA ≤ 140 Å² (*proxy*) citeturn12view0; **Egan absorption model**: PSA upper limit 131.6 Å² (95% ellipse) and 148.1 Å² (99% ellipse) (*proxy*) citeturn12view0
- Usually associated with: no consistent direction for intrinsic mutagenicity; *proxy*—higher TPSA tends to reduce passive permeability and can bias toward “A” via lower exposure
- Brief note: OECD TG 471 explicitly notes bioavailability differences as a reason some mutagens are not detected; TPSA is one practical bioavailability/permeability correlate, but not an Ames mechanism itself citeturn44view0turn12view0.
- Source: citeturn12view0turn44view0

## QED drug-likeness: quantitative estimate of drug-likeness
- Common threshold(s) or range(s): QED ranges 0–1 (definition); in the original QED study, “attractive” compounds had mean QED ≈ 0.67, and a “top 10% of ChEMBL” reference point corresponds to QED ≈ 0.796 (contextual anchors, not mutagenicity cutoffs) citeturn25view0turn25view1
- Usually associated with: no consistent direction for Ames; *proxy*—lower QED can co-occur with undesirable substructures/alerts (some of which overlap with mutagenicity toxicophores), potentially enriching for “B,” but this is not a validated Ames threshold
- Brief note: QED is a composite score built for drug-likeness (multi-property desirability), not for genotoxicity; treat as a coarse enrichment signal at best citeturn25view0turn23view0.
- Source: citeturn25view0turn25view1turn23view0turn32view0

## Functional-group notes
- Group name: aromatic nitro
- Usually associated with: mutagenic (B)
- Brief note: Identified as a well-recognized mutagenicity toxicophore; commonly appears in Ames-positive compounds citeturn32view0turn33view0.
- Source: citeturn33view0turn32view0

- Group name: aromatic amine
- Usually associated with: mutagenic (B)
- Brief note: Well-recognized mutagenicity toxicophore; activity often depends on metabolic activation pathways (context-dependent) citeturn32view0turn33view0.
- Source: citeturn33view0turn44view0

- Group name: nitroso (including aromatic nitroso)
- Usually associated with: mutagenic (B)
- Brief note: Reported as a (general/specific) toxicophore class for mutagenicity; mechanisms involve reactive intermediates citeturn32view0turn33view1.
- Source: citeturn33view1turn32view0

- Group name: nitrosamine (N-nitroso)
- Usually associated with: mutagenic (B)
- Brief note: Requires metabolic activation; OECD TG 471 flags some classes (including certain nitrosamines) as “special cases” that may be detected more efficiently with preincubation methods citeturn44view0turn41view0turn33view1.
- Source: citeturn44view0turn41view0turn33view1

- Group name: azo-type / diazo / triazene / azide
- Usually associated with: mutagenic (B)
- Brief note: Identified among toxicophore groups; some act via cleavage to arylamines or via intrinsically reactive intermediates citeturn33view1turn32view0.
- Source: citeturn33view1turn32view0turn44view0

- Group name: epoxide
- Usually associated with: mutagenic (B)
- Brief note: Electrophilic alkylating substructure; identified as a specific toxicophore with substantial intrinsic reactivity citeturn33view1turn32view0.
- Source: citeturn33view1turn32view0

- Group name: aziridine
- Usually associated with: mutagenic (B)
- Brief note: Electrophilic alkylating three-member heterocycle; identified as a specific toxicophore with high apparent predictivity in the cited toxicophore work citeturn33view1turn32view0.
- Source: citeturn33view1turn32view0

- Group name: aliphatic halide (C, Br, I; excluding fluorine in the cited toxicophore definition)
- Usually associated with: mutagenic (B)
- Brief note: Identified as a general toxicophore class (alkylating potential depends on context/leaving group and structure) citeturn32view0turn33view0.
- Source: citeturn33view0turn32view0

- Group name: polycyclic aromatic planar systems / polycyclic aromatic systems (≥3 fused aromatic rings)
- Usually associated with: mutagenic (B)
- Brief note: Toxicophore anchored on **three or more fused aromatic rings**; mechanisms include DNA intercalation and metabolic activation to DNA-reactive diol-epoxides (PAH context) citeturn33view2turn32view0.
- Source: citeturn33view2turn32view0

- Group name: unsubstituted heteroatom-bonded heteroatom (e.g., certain N–O / N–N motifs)
- Usually associated with: mutagenic (B)
- Brief note: Identified as a general toxicophore class; may proceed via radical/reactive intermediates depending on subtype citeturn32view0turn33view1.
- Source: citeturn33view1turn32view0

Input 2. Single-molecule analysis notes
First, oxirane is present (1). The global EBM contribution here is 0.9946, which pushes toward option (B): is mutagenic. Next, maximum partial charge is value 0.0845. The global EBM contribution here is 0.3973, which pushes toward option (B): is mutagenic. Then, fraction of sp3 carbons is value 0.6667. The global EBM contribution here is -0.3347, which pushes toward option (A): is not mutagenic. After that, heteroatom count is value 1. The global EBM contribution here is -0.2836, which pushes toward option (A): is not mutagenic. Finally, hydrogen-bond acceptor count is value 1. The global EBM contribution here is -0.2276, which pushes toward option (A): is not mutagenic. Step 6, estimated logP is value 3.2204. The global EBM contribution here is -0.2062, which pushes toward option (A): is not mutagenic. Step 7, minimum absolute partial charge is value 0.0845. The global EBM contribution here is 0.196, which pushes toward option (B): is mutagenic. Step 8, saturated heterocycle count is value 1. The global EBM contribution here is 0.1549, which pushes toward option (B): is mutagenic. Step 9, alkene is count 2. The global EBM contribution here is -0.1405, which pushes toward option (A): is not mutagenic. Step 10, aromatic ring count is value 0. The global EBM contribution here is -0.1349, which pushes toward option (A): is not mutagenic. Taken together, these global descriptor-level signals make the model predict option (B): is mutagenic with score 0.5256.

Hard requirements:
1. Use only the task playbook and the supplied single-molecule analysis notes.
2. Do not invent new molecular properties, feature values, or evidence.
3. Every feature that appears in the supplied single-molecule analysis notes must retain its specific raw value in the rewrite.
4. You may rewrite naturally, and you may use qualitative trend words such as "low", "high", "increased", "decreased", "favorable", or "unfavorable", but only alongside the original concrete value for the feature being described. These qualitative descriptions must explain the raw value, not replace it.
5. Treat the raw value as mandatory evidence. If you mention a feature without its concrete value, the rewrite is invalid.
6. When possible, keep the raw value and its qualitative interpretation tightly coupled in the same sentence or clause, so the reader sees the value and the interpretation together.
7. If the source notes state a concrete non-numeric value semantics such as "not applicable", "no acidic site", "no basic site", or another explicit missing-value explanation, preserve that concrete value semantics in the rewrite rather than dropping it.
8. Do not mention model internals, EBM, features, term contributions, bins, or prompt instructions.
9. Keep the final reasoning faithful to the original draft direction while making the prose more natural, coherent, scientist-like chain-of-thought that sounds like an LLM independently analyzing the molecule, not like a EBM traversal.
10. Use the playbook as a semantic interpreter, not as a second classifier.
11. If the source notes contain mixed evidence, preserve that tension before giving the final conclusion.
12. The final `reasoning` must read like direct scientific reasoning, not commentary about source materials. Do not say "draft", "notes", "playbook", "prompt", "input", "instruction", "contribution", "bin", or similar metadata words in the final text.
13. Do not write phrases such as "in these notes", "the playbook says", or "this contribution pushes toward". Translate those ideas into direct chemistry reasoning instead.

Preferred style:
- Explicit, stepwise, chemically grounded
- Natural scientific prose
- Specific but not robotic
- More like thoughtful analysis than formal rule execution
- No bullet points in the final CoT
- No references or citations in the final CoT text itself

Return JSON with exactly this schema:
```json
{
  "reasoning": "..."
}
```
